Enterics for Global Health (EFGH)
NCT06047821 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 9800
Last updated 2025-01-14
Summary
Diarrhea remains a leading cause of death among young children, with the majority of diarrhea deaths occurring in low- and middle-income countries. Childhood diarrhea caused by a type of bacteria called "Shigella" is responsible for an estimated 60,000 deaths each year and may cause particularly severe illness among children. Currently, there are several promising vaccines to prevent Shigella diarrhea in development, but key information is still needed to inform future vaccine studies. The purpose of this study, titled Enterics for Global Health (or the "EFGH"), is to determine the number and rate of new cases of Shigella diarrhea among children 6 to 35 months of age presenting to health facilities with diarrhea or dysentery. Over a two-year period, the EFGH study will enroll 1,400 children from each of the seven countries: Peru, Pakistan, Bangladesh, Mali, Malawi, Kenya, and The Gambia (9,800 children total).
Conditions
- Shigella
- Child
- Diarrhea
Sponsors & Collaborators
-
Aga Khan University
collaborator OTHER -
International Centre for Diarrhoeal Disease Research, Bangladesh
collaborator OTHER -
University of Maryland, Baltimore
collaborator OTHER -
University of Virginia
collaborator OTHER -
Asociacion Benefica Prisma
collaborator OTHER -
Medical Research Council Unit, The Gambia
collaborator OTHER -
Kenya Medical Research Institute
collaborator OTHER -
Center for Vaccine Development - Mali
collaborator OTHER -
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
collaborator OTHER -
Bill and Melinda Gates Foundation
collaborator OTHER - lead OTHER
Principal Investigators
-
Patricia B Pavlinac, PhD · University of Washington
Eligibility
- Min Age
- 6 Months
- Max Age
- 35 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-25
- Primary Completion
- 2024-08-17
- Completion
- 2025-04-30
Countries
- Bangladesh
- Kenya
- Malawi
- Mali
- Pakistan
- Peru
- The Gambia
Study Locations
More Related Trials
-
Improving Care Through Azithromycin Research for Infants in Africa
NCT04235816 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Descriptive Study of Pathogens Involved in Summer Diarrhea in Children Leading to Pediatric Emergency Room Visits (PE-DIA)
NCT04209751 ·Status: COMPLETED
-
SHINE Sanitation, Hygiene, Infant Nutrition Efficacy Project
NCT01824940 ·Status: COMPLETED ·Phase: NA
-
Post Discharge Trial to Enhance Immunity in Severely Malnourished Children
NCT06530485 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Relative Efficacy of Two Regimens of Ante-helminthic Treatment
NCT00367627 ·Status: COMPLETED ·Phase: NA
-
An Epidemiological Surveillance Study to Determine the Incidence of ETEC in Children and Infants in Lusaka
NCT04838587 ·Status: COMPLETED
-
Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories
NCT07195006 ·Status: RECRUITING
-
Microbiota Directed Food for Children With Severe Acute Malnutrition
NCT06308848 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Investigating Typhoid Fever Pathogenesis
NCT03067961 ·Status: UNKNOWN ·Phase: NA
-
Zinc Supplementation in Shigella Patients
NCT00321126 ·Status: COMPLETED ·Phase: PHASE3
-
Registry and Clinical Observation of Children With Diarrhoeal Disease
NCT05052489 ·Status: UNKNOWN
-
Studies of Immune Responses to Orally Administered Vaccines in Developing Country
NCT01019083 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic Resistance
NCT03465488 ·Status: COMPLETED ·Phase: NA
-
Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan
NCT07207434 ·Status: RECRUITING ·Phase: PHASE2
-
A Comprehensive Analysis of the Comparative Efficacy of Multimodal Diarrhea Therapies in the Paediatric Population
NCT06588036 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan
NCT01202201 ·Status: COMPLETED
-
Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance
NCT04853186 ·Status: RECRUITING
-
Antibacterial Treatment Against Diarrhea in Oral Rehydration Solution
NCT00937274 ·Status: TERMINATED ·Phase: NA
-
Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults
NCT03910972 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of Age
NCT04061538 ·Status: COMPLETED ·Phase: NA
-
Preventative Intervention for Cholera for 7 Days
NCT05166850 ·Status: RECRUITING ·Phase: NA
-
Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control Efforts
NCT02864433 ·Status: COMPLETED
-
Transmission and the Respiratory Tract in Cryptosporidiosis
NCT00507871 ·Status: COMPLETED
-
Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso
NCT03187834 ·Status: COMPLETED ·Phase: PHASE4
-
EFFICACY AND SAFETY OF XILOGLUCAN IN ACUTE GASTROENTERITIS IN CHILDREN
NCT03357237 ·Status: UNKNOWN ·Phase: NA